Brief: Briacell Awarded $2 Million Nci Grant To Advance Bria-Pros+™ In Prostate Cancer
25/08/2025 12:38
Aug 25 (Reuters) - Briacell Therapeutics Corp BCT.TO: BRIACELL AWARDED $2 MILLION NCI GRANT TO ADVANCE BRIA-PROS+™ IN PROSTATE CANCER Source text: ID:nGNX8Knmvk Further company coverage: BCT.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study